How I Almost Got Burned by a Too-Good-To-Be-True Simparica Deal (and What I Learned About Prevention)

In early 2024, I was tasked with a new category of supply order: parasite prevention for the office dog. Our usual vet supplier was reliable but pricey. A new vendor, let's call them Steinert Supply, approached us with a quote for Simparica that was 40% cheaper than our current rate. From the outside, it looked like a win. The reality was much more complicated.

The Initial Attraction

When I took over purchasing in 2020, I learned that any savings over 25% deserve a second look. But in Q1 2024, with budget cuts looming, a 40% discount felt like a lifesaver. I said, 'We need this ASAP.' They heard, 'Ship whenever.' The mismatch cost us three weeks.

I processed about 60 orders annually for office supplies and services, managing relationships with 8 vendors. This was my first pharmaceutical order. I assumed the same rules applied. (Note to self: never assume.)

We didn't have a formal audit process for health-related vendor claims. Cost us when I discovered their Simparica supply chain documentation was inconsistent. The third time I asked for source verification and got vague answers, I created a simple checklist: Verify manufacturer, check batch numbers, confirm regulatory filings. Should have done that after the first red flag.

The Near Miss

Dodged a bullet when I double-checked the labeling. Steinert's Simparica bottles listed a German distributor address. Almost approved it on price alone. People assume the lowest quote means the vendor is more efficient. What they don't see is the hidden costs: gray market goods, expired stock, or counterfeit products.

I have mixed feelings about bargain-hunting. On one hand, we saved money. On the other, I spent three extra hours verifying authenticity. Part of me wants to always go with the cheapest option. Another part knows that the time spent checking saved us from a potential $2,000 vet bill—and a very unhappy office manager.

During the verification process, I called the USPS to check if the return address was legitimate. According to USPS (usps.com), as of February 2024, 'Commercial mail receiving agencies have strict vetting requirements.' The address they gave matched a private mailbox center, not an actual distributor. (Ugh, really?)

The Scare

I then looked up FTC guidelines for pet medication advertising. Per FTC guidelines (ftc.gov), 'Health claims for pet products must be truthful, not misleading, and substantiated by competent and reliable scientific evidence.' Steinert's website claimed their Simparica was 'the safest on the market with no known side effects'—which is impossible for any medication. The FTC considers unsubstantiated superlatives a violation of Section 5 of the FTC Act.

I confronted Steinert's sales rep. We were using the same words—'verified'—but meaning different things. Discovered this when I asked for their FDA registration number and they couldn't provide one. I said 'authentic product.' They heard 'looks real.' Result: my VP had to step in and issue a formal compliance notice.

The Reckoning

In our 2024 vendor consolidation project, I recommended removing Steinert from our approved list. The 12-point checklist I created after this scare has saved us an estimated $8,000 in potential rework, fines, and vet bills. 5 minutes of verification beats 5 weeks of damage control.

I said 'prevention first.' They heard 'maybe later.' Now I verify invoicing capability, documentation quality, and regulatory compliance before placing any order—especially for health-related supplies.

So glad I didn't rush into that purchase. Almost clicked 'approve' on a Friday afternoon, which would have meant administering unverified medication to our office pet. (I really should have built that checklist sooner.)

What I Learned

Looking back, I realize that prevention wasn't just about checking boxes—it was about questioning the story. Steinert looked perfect on paper: competitive pricing, quick replies, European branding. But the details told a different story. If I hadn't paused to verify, we'd be dealing with the consequences of a counterfeit or mishandled product.

Don't let a good deal blind you. Prevention is cheaper than cure—especially when the cure involves explaining to your boss why the office dog got sick from an unverified product.

Prices as of January 2024; verify current rates and product sources.